Inspiratory Muscle Training With Normocapnic Hyperpnea in Chronic Obstructive Pulmonary Disease (COPD)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified October 2010 by Università degli Studi di Ferrara.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
Università degli Studi di Ferrara
ClinicalTrials.gov Identifier:
NCT01218295
First received: October 7, 2010
Last updated: October 8, 2010
Last verified: October 2010

October 7, 2010
October 8, 2010
May 2009
June 2011   (final data collection date for primary outcome measure)
Exercise Capacity [ Time Frame: 1 month ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT01218295 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Inspiratory Muscle Training With Normocapnic Hyperpnea in Chronic Obstructive Pulmonary Disease (COPD)
Efficacy of Inspiratory Muscle Training by Means of Spirotiger® in COPD Patients.

Many studies suggest that inspiratory muscles training by means of normocapnic hyperpnea improves exercise tolerance in healthy subjects. No information is available about the use of this training in COPD patients even if other methods (such as threshold loading and resistive loading) have been shown to be effective in terms of Inspiratory Muscle Function, Health-Related Quality of Life and Exercise Tolerance.

This study is designed to evaluate the effects of normocapnic hyperventilation by means of Spirotiger®, an instrument training the respiratory muscles, avoiding hypocapnia (using the methodology of isocapnic hyperpnoea)in COPD patients.

---

Interventional
Not Provided
Allocation: Non-Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
COPD
Device: Spirotiger®
training session :10 minutes twice a day X 4 weeks
Other Name: Pulmonary rehabilitation
Experimental: Respiratory muscle training
Patients assigned to this arm train the respiratory muscles by means of normocapnic hyperpnea.
Intervention: Device: Spirotiger®
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
20
July 2011
June 2011   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • COPD patients. All patients are at stable state, free from an exacerbation from at least 3 months.

Exclusion Criteria:

  • COPD patients with a recent history of cardiovascular disease, neurologic disease and other diseases that would interfere with the training.
Both
40 Years to 85 Years
Yes
Contact: Annalisa Cogo, MD +390532210420 cga@unife.it
Contact: Luca Pomidori, PhD +390532455888 pmdlcu@unife.it
Italy
 
NCT01218295
IMTCOPD2
No
Annalisa Cogo, University of Ferrara
Università degli Studi di Ferrara
Not Provided
Principal Investigator: Annalisa Cogo, MD Università di Ferrara
Università degli Studi di Ferrara
October 2010

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP